Clinical trialObsUnknown
PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer
- Outcome
- Outcome unknown
- Phase
- Obs
- Status
- Unknown
- Study type
- Observational
- Start
- 1 February 2021
- Expected end
- 30 June 2025
- Enrollment
- 126 participants
- Sites
- 1
- Primary outcomes
- Incidence of pancreatic ductal adenocarcinoma (PDAC) in the high predicted risk group
- Sponsor
- Other
- Results posted
- No
- Last update
- 16 January 2024
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
Conduct a prospective study to assess the accuracy of a pancreatic cancer risk prediction model.
Detailed description public domain (ClinicalTrials.gov)
The goal of this study is to establish a platform for development and implementation of a data-driven risk model for detection of early stage pancreatic cancer within an integrated health care setting. Patients at increased risk for pancreatic cancer as identified by the risk model will be invited to participate in a prospective study to assess the accuracy of this approach for detection of early stage pancreatic cancer.